InsiderClue
← All stocks

Coya Therapeutics, Inc.

COYA Net buying
CIK 0001835022 #4271 in the set updated 22 Sep 2026
Bought (120 mo)
$110.01K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$110.01K
+$110.01K against sales at will

By person

9 insiders · 14 transactions
0.1×

Arun Swaminathan holds only 0.1 times base salary in stock. $71.86K of shares against $546.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Arun Swaminathan last reported holding, valued at $7.19, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Nov 2024.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Swaminathan Arun
Chief Executive Officer
$73.49K (2)
—
+$73.49K
10,000
0.0426%
$71.86K
—
Grossman Fred
Chief Medical Officer
$19.97K (1)
—
+$19.97K
2,710
0.0116%
$19.47K
—
SNYDER DAVID S
Chief Financial Officer
$12.93K (2)
—
+$12.93K
8,800
0.0375%
$63.24K
—
Lee Ann
Director
$3.62K (2)
—
+$3.62K
33,958
0.1448%
$244.02K
+106.1%
Berman Howard
Executive Chairman
— (1)
—
$0.00
10,000
0.0426%
$71.86K
—
Garren Hideki
Director
— (1)
—
$0.00
2,000
0.0085%
$14.37K
—
GOLDSTEIN DOV A MD
Director
— (1)
—
$0.00
27,557
0.1175%
$198.02K
—
Hepner Adrian
Chief Medical Officer
— (1)
—
$0.00
10,000
0.0426%
$71.86K
—
Villalobos Anabella
Director
— (1)
—
$0.00
10,000
0.0426%
$71.86K
—

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
SNYDER DAVID S
14 Nov 2024
Chief Financial Officer
Buy
1,800
$7.19
$12.93K
Swaminathan Arun
13 Nov 2024
Chief Executive Officer
Buy
5,000
$7.36
$36.80K
Swaminathan Arun
11 Nov 2024
Chief Executive Officer
Buy
5,000
$7.34
$36.69K
Grossman Fred
11 Nov 2024
Chief Medical Officer
Buy
2,710
$7.37
$19.97K
Lee Ann
22 Aug 2023
Director
Buy indirect
1,000
$3.62
$3.62K
GOLDSTEIN DOV A MD
3 Jan 2023
Director
Buy
10,000
—
no price
Villalobos Anabella
3 Jan 2023
Director
Buy
10,000
—
no price
SNYDER DAVID S
3 Jan 2023
Chief Financial Officer
Buy
7,000
—
no price
Garren Hideki
3 Jan 2023
Director
Buy
2,000
—
no price
Hepner Adrian
3 Jan 2023
Chief Medical Officer
Buy
10,000
—
no price
Lee Ann
3 Jan 2023
Director
Buy
10,000
—
no price
Berman Howard
3 Jan 2023
Chief Executive Officer
Buy
10,000
—
no price
Show all 14 transactions →

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 7
Shares from compensation/vesting 24,036
History held since 4 Jan 2023